D-Wave Quantum: Record Backlog, a Scientific Squall, and a Washington-Backed Ambition

D-Wave navigates quantum benchmark dispute, record Q1 bookings, $100M CHIPS Act support, and insider share sale amid 54% 30-day stock surge.

D-Wave Quantum is catching crosswinds this week. A scientific challenge to its core quantum claims landed just as the company prepared to pitch investors at the TD Cowen Sustainability & Industrial Innovation Conference. Then came a fresh wave of federal backing, record bookings, and an insider share sale that left the stock zigzagging — volatility that its 133% annualised volatility statistic neatly captures for a name that has climbed 54% in the last 30 days.

Scientific credibility under fire

Two days before its conference appearance, D-Wave was forced to defend its performance benchmarks after the Flatiron Institute published a study arguing that classical simulation algorithms could match the output of its quantum processors. D-Wave’s technical leadership pushed back hard, pointing out that the algorithms tested had failed on the most complex three-dimensional spin-glass problems on cubic and diamond lattices. The company insists its “beyond-classical” benchmarks remain valid — a rebuttal that helped stabilise the stock after a mid-week dip. The shares recently changed hands at roughly €23, still about 40% below the 52-week high of €38.48, but more than double the year low set in late March.

A split-screen quarter

The first quarter of 2026 delivered a stark contradiction. Bookings hit a record $33.4 million — a near-2,000% surge from a year earlier — and remaining performance obligations jumped 563% to $42.4 million. Yet reported revenue collapsed to just $2.86 million, 81% below the prior-year period and well short of the $4.14 million consensus estimate. The drop was largely due to a one-off system sale in the year-ago quarter that distorted the comparison. On the bottom line, the loss per share of $0.05 beat the expected $0.08 loss. The company holds roughly $588 million in cash and securities, and its market capitalisation sits around $10 billion — a price-to-sales multiple near 791 that rests almost entirely on hope that those bookings convert into hard revenue.

Washington deepens its bet

The U.S. Department of Commerce has delivered a non-binding letter of intent for $100 million under the CHIPS and Science Act, intended to accelerate D-Wave’s annealing and gate-model system development. In an unusual structure, the government would receive equity in exchange for the grant, effectively becoming a shareholder — a clear signal of D-Wave’s strategic importance to Washington. Part of the funding would support a new research and development centre in Boca Raton, Florida, adding to existing sites in New Haven and Burnaby. Separately, D-Wave has secured the second-year tranche of its SQFab project, part of a $25 million package through the NORDTECH consortium and the U.S. Microelectronics Commons program.

Insider selling meets institutional buying

A day after the Commerce announcement, chief financial officer John M. Markovich sold roughly 329,000 shares at an average of $27.70 each, netting about $9.1 million. The sale followed the exercise of stock options and cut his direct holdings by nearly 19%, leaving him with about 1.44 million shares. That move sits against a broader pattern: industry-wide, insiders at D-Wave, IonQ, and Rigetti have sold a net $931 million in shares over five years, with D-Wave alone accounting for $295 million in sales versus just $309,000 in insider purchases over the same period.

Institutional investors have taken the opposite view. Vanguard boosted its stake by 41% to 38.45 million shares, while UBS raised its position by more than 540% to 12.09 million shares. Funds and institutions now collectively own roughly 42% of the company.

The next proving ground: London

With the stock’s valuation so dependent on future revenue conversion, the critical test comes on June 18 in London at the Qubits Europe 2026 conference. D-Wave plans to showcase real-world applications of its dual-platform technology in logistics, artificial intelligence, and materials science. For a share price that trades almost entirely on expectations, tangible customer use cases may ultimately tell a more convincing story than any quarterly filing.